Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$770M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$580M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$391M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$322M |
| 5 |
UnitedHealth
UNH
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 3 |
RP
RealPage, Inc.
RP
|
+$316M |
| 4 |
Shopify
SHOP
|
+$312M |
| 5 |
Boeing
BA
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.82% |
| 2 | Healthcare | 7.16% |
| 3 | Financials | 5.78% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Industrials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCS
3401
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.99M | ﹤0.01% |
15,309
-390
| -2% | -$81.1K |
|
|
GXIIU
3402
DELISTED
GX Acquisition Corp. II Unit
GXIIU
| $2.99M | ﹤0.01% |
300,000
-1,050,000
| -78% | -$10.5M |
|
|
JCIC
3403
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
| $2.99M | ﹤0.01% |
+310,807
| New | +$3.02M |
|
|
AKUS
3404
DELISTED
Akouos Inc
AKUS
| $2.99M | ﹤0.01% |
238,506
+68,820
| +41% | +$933K |
|
3405
Deere & Co
DE
$160B
| $2.99M | ﹤0.01% |
8,483
-272,378
| -97% | -$99.4M |
|
3406
Barnes & Noble Education
BNED
$431M
| $2.99M | ﹤0.01% |
4,149
-3,824
| -48% | -$3.08M |
|
3407
Donaldson
DCI
$10.9B
| $2.98M | ﹤0.01% |
46,913
-426,140
| -90% | -$26.3M |
|
3408
CALL
Fastly Inc
FSLY
$3.55B
| $2.98M | ﹤0.01% |
50,000
+20,000
| +67% | +$1.14M |
|
3409
Liberty Latin America Class C
LILAK
$1.63B
| $2.98M | ﹤0.01% |
232,507
+71,142
| +44% | +$913K |
|
|
BZUN
3410
Baozun
BZUN
$167M
| $2.98M | ﹤0.01% |
+83,934
| New | +$2.96M |
|
3411
DNOW Inc
DNOW
$2.58B
| $2.98M | ﹤0.01% |
+313,436
| New | +$3.24M |
|
3412
iShares Select Dividend ETF
DVY
$23.5B
| $2.98M | ﹤0.01% |
25,506
+4,895
| +24% | +$582K |
|
3413
Acadia Pharmaceuticals
ACAD
$4.43B
| $2.97M | ﹤0.01% |
121,931
+110,131
| +933% | +$2.49M |
|
3414
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| $2.97M | ﹤0.01% |
+300,000
| New | +$3.18M |
|
3415
LiveOne
LVO
$61.7M
| $2.96M | ﹤0.01% |
62,788
+38,441
| +158% | +$1.67M |
|
3416
Sanmina
SANM
$9.95B
| $2.96M | ﹤0.01% |
76,071
+53,184
| +232% | +$2.19M |
|
3417
United Natural Foods
UNFI
$3.08B
| $2.96M | ﹤0.01% |
79,987
+69,203
| +642% | +$2.52M |
|
|
CYT
3418
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $2.96M | ﹤0.01% |
+138,165
| New | +$2.59M |
|
|
NRACU
3419
DELISTED
Northern Revival Acquisition Corporation Unit
NRACU
| $2.96M | ﹤0.01% |
295,729
-106,771
| -27% | -$1.06M |
|
|
MACQ
3420
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
| $2.96M | ﹤0.01% |
+307,221
| New | +$2.98M |
|
3421
Fennec Pharmaceuticals
FENC
$332M
| $2.95M | ﹤0.01% |
+404,772
| New | +$2.7M |
|
|
IPVF
3422
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
| $2.95M | ﹤0.01% |
+304,203
| New | +$2.96M |
|
|
BCPC
3423
Balchem Corp
BCPC
$5.38B
| $2.95M | ﹤0.01% |
22,455
+16,764
| +295% | +$2.16M |
|
3424
Old Republic International
ORI
$10.5B
| $2.95M | ﹤0.01% |
+118,248
| New | +$2.97M |
|
|
SHOE
3425
Shoe Station Group
SHOE
$413M
| $2.94M | ﹤0.01% |
82,150
+74,072
| +917% | +$2.4M |
|
Similar funds
Millennium Management's Q2 2021 Portfolio in Review
As of Q2 2021, Millennium Management held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $13.3B of net new capital in Q2 2021, opening 1,693 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.
- Millennium Management's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
- Millennium Management added most to Linde in Q2 2021, an estimated $770M increase.
- Millennium Management's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
- Millennium Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
- Millennium Management's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
- Millennium Management opened 1,693 new positions and closed 1,074 in Q2 2021.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $163B.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.